• promising nanotechnology stocks to watch now – july 16th Defense World Fri, 18 Jul 2025 07:00:00 GMT
• virpax pharmaceuticals (nasdaq:vrpx) trading down 2.9% – should you sell? Defense World Fri, 11 Jul 2025 12:44:05 GMT
• promising nanotechnology stocks to add to your watchlist – july 9th Defense World Fri, 11 Jul 2025 07:29:12 GMT
• promising nanotechnology stocks to add to your watchlist - july 9th MarketBeat Wed, 09 Jul 2025 21:11:48 GMT
• virpax pharmaceuticals (nasdaq:vrpx) trading 3.7% higher – what’s next? Defense World Thu, 19 Jun 2025 07:00:00 GMT
• best nanotechnology stocks to add to your watchlist - june 16th MarketBeat Wed, 18 Jun 2025 21:28:57 GMT
• best nanotechnology stocks to add to your watchlist - june 16th MarketBeat Mon, 16 Jun 2025 20:43:39 GMT
• virpax pharmaceuticals (nasdaq:vrpx) trading 4.4% higher – still a buy? Defense World Wed, 28 May 2025 13:51:34 GMT
• virpax and nanomerics enter technology license agreement for developing a product for ptsd treatment StatNano Wed, 14 May 2025 00:28:09 GMT
• promising nanotechnology stocks to watch now – may 7th The AM Reporter Fri, 09 May 2025 10:21:37 GMT
• virpax pharmaceuticals (nasdaq:vrpx) trading up 5.5% – here’s what happened Defense World Tue, 06 May 2025 07:00:00 GMT
• virpax(r) pharmaceuticals announces appointment of michèle c. linde, evp, general counsel ACCESS Newswire Sat, 03 May 2025 01:38:49 GMT
• virpax pharmaceuticals, inc. (nasdaq:vrpx) sees large increase in short interest Defense World Tue, 15 Apr 2025 05:14:39 GMT
• virpax pharmaceuticals to present nes100 toxicity study at major toxicology conference MSN Wed, 09 Apr 2025 21:45:57 GMT
• vrpx stock plunges to 52-week low, touches $1.07 Investing.com Australia Fri, 04 Apr 2025 07:00:00 GMT
• vrpx stock plunges to 52-week low, touches $1.07 by investing.com Investing.com Australia Fri, 04 Apr 2025 07:00:00 GMT
• virpax pharmaceuticals stock plummets on nasdaq delisting news by investing.com Investing.com Australia Fri, 04 Apr 2025 07:00:00 GMT
• Virpax Pharmaceuticals stock plummets on Nasdaq delisting news Investing.com Thu, 03 Apr 2025 07:00:00 GMT
• virpax pharmaceuticals faces nasdaq delisting notice and leadership changes TipRanks Thu, 03 Apr 2025 07:00:00 GMT
• Virpax Pharmaceuticals Faces Nasdaq Delisting Notice and Leadership Changes TipRanks Wed, 02 Apr 2025 07:00:00 GMT
• promising nanotechnology stocks to watch now - march 22nd MarketBeat Wed, 26 Mar 2025 07:00:00 GMT
• virpax pharmaceuticals enacts 1-for-25 reverse stock split by investing.com Investing.com Australia Sat, 22 Mar 2025 07:00:00 GMT
• virpax pharmaceuticals enacts 1-for-25 reverse stock split Investing.com Fri, 21 Mar 2025 07:00:00 GMT
• vrpx stock plunges to 52-week low of $0.12 amid market challenges Investing.com Australia Fri, 21 Mar 2025 01:47:38 GMT
• virpax pharmaceuticals announces the formation of novvae™ pharmaceuticals Business Wire Thu, 20 Mar 2025 22:22:15 GMT
• Virpax Pharmaceuticals announces 1-for-25 reverse stock split Investing.com Wed, 19 Mar 2025 07:00:00 GMT
• VRPX stock plunges to 52-week low of $0.12 amid market challenges Investing.com Wed, 19 Mar 2025 07:00:00 GMT
• exchange-traded funds, equity futures higher pre-bell wednesday ahead of fed rate decision TradingView Wed, 19 Mar 2025 07:00:00 GMT
• virpax announces major 1:25 reverse split to maintain nasdaq listing Stock Titan Wed, 19 Mar 2025 07:00:00 GMT
• virpax reports positive results from dose range finding study of pain relief treatment in beagle dogs MarketScreener Wed, 19 Mar 2025 07:00:00 GMT
• Breakthrough: Virpax's 5-Day Pain Drug Passes Critical Safety Test Stock Titan Tue, 18 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in tuesday's pre-market session Benzinga Tue, 18 Mar 2025 07:00:00 GMT
• virpax receives positive probudur(tm) results for dose range study marketscreener.com Tue, 18 Mar 2025 07:00:00 GMT
• virpax receives positive probudur results for dose range study TipRanks Tue, 18 Mar 2025 07:00:00 GMT
• virpax pharmaceuticals to present nes100 toxicity study at major toxicology conference MSN Mon, 17 Mar 2025 07:28:40 GMT
• virpax pharmaceuticals to present nes100 toxicity study at major toxicology conference MSN Sun, 16 Mar 2025 08:28:44 GMT
• endo, inc. to sell international pharmaceuticals business to knight therapeutics MyChesCo Fri, 14 Mar 2025 12:00:00 GMT
• virpax pharmaceuticals to present nes100 toxicity study at major toxicology conference MSN Fri, 14 Mar 2025 00:27:21 GMT
• virpax pharmaceuticals explores intranasal mrna vaccine delivery using met MSN Thu, 13 Mar 2025 11:04:14 GMT
• virpax pharmaceuticals stock hits 52-week low at $0.18 by investing.com Investing.com Australia Wed, 12 Mar 2025 07:00:00 GMT
• virpax pharmaceuticals explores intranasal mrna vaccine delivery using met MyChesCo Tue, 11 Mar 2025 07:00:00 GMT
• virpax pharmaceuticals stock hits 52-week low at $0.18 Investing.com Tue, 11 Mar 2025 07:00:00 GMT
• virpax pharmaceuticals to present nes100 toxicity study at major toxicology conference MyChesCo Tue, 11 Mar 2025 06:00:00 GMT
• virpax looking to use met to develop intranasal covid vaccine -march 07, 2025 at 08:36 am est Marketscreener.com Fri, 07 Mar 2025 13:36:15 GMT
• virpax pharmaceuticals applauds successful trial of molecular envelope technology MSN Fri, 07 Mar 2025 10:12:23 GMT
• could this needle-free covid vaccine technology transform vaccine delivery? Stock Titan Fri, 07 Mar 2025 08:00:00 GMT
• virpax pharmaceuticals applauds successful trial of molecular envelope technology MSN Thu, 06 Mar 2025 01:23:32 GMT
• vrpx - virpax pharmaceuticals inc latest stock news & market updates StockTitan Wed, 05 Mar 2025 21:01:00 GMT
• virpax’s nes100 to be presented at the society of toxicology by ncats Business Wire Wed, 05 Mar 2025 08:00:00 GMT
• can virpax's nasal pain treatment solve the opioid addiction problem? StockTitan Wed, 05 Mar 2025 08:00:00 GMT
• virpax pharmaceuticals applauds successful trial of molecular envelope technology MSN Wed, 05 Mar 2025 01:35:23 GMT
• stock market update – virpax pharmaceuticals stock price prediction 2025 ldccbank Tue, 04 Mar 2025 07:54:54 GMT
• virpax pharmaceuticals applauds successful trial of molecular envelope technology MyChesCo Mon, 03 Mar 2025 08:00:00 GMT
• virpax pharmaceuticals, inc. (nasdaq:vrpx) short interest update The AM Reporter Mon, 03 Mar 2025 08:00:00 GMT
• short interest in virpax pharmaceuticals, inc. (nasdaq:vrpx) expands by 148.7% Defense World Sat, 01 Mar 2025 08:00:00 GMT
• virpax pharmaceuticals stock price, quotes and forecasts | nasdaq:vrpx Benzinga Fri, 28 Feb 2025 20:07:18 GMT
• vrpx soars on met results, coll projects 16%-19% revenue growth in 2025, rpid gains momentum RTTNews Fri, 28 Feb 2025 08:00:00 GMT
• virpax lauds nanomerics’ met study with no severe side effects by investing.com Investing.com India Fri, 28 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals reports molecular envelope technology human study data TipRanks Fri, 28 Feb 2025 04:16:37 GMT
• virpax(r) pharmaceuticals to present at thinkequity conference ACCESS Newswire Thu, 27 Feb 2025 11:33:14 GMT
• Can Virpax's Breakthrough Drug Delivery Tech Transform Pain Management Without Opioid Risks? Stock Titan Thu, 27 Feb 2025 08:00:00 GMT
• virpax lauds nanomerics' met study with no severe side effects Investing.com Thu, 27 Feb 2025 08:00:00 GMT
• virpax lauds nanomerics’ met study with no severe side effects by investing.com Investing.com South Africa Thu, 27 Feb 2025 08:00:00 GMT
• virpax reports positive results in human study for its molecular envelope technology Business Wire Thu, 27 Feb 2025 08:00:00 GMT
• vrpx stock touches 52-week low at $0.23 amid market challenges Investing.com Wed, 26 Feb 2025 08:00:00 GMT
• maxona pharmaceuticals secures new patent for innovative pain therapy MyChesCo Wed, 26 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals advances pain management with promising probudur study results MSN Thu, 20 Feb 2025 15:35:59 GMT
• virpax pharmaceuticals advances pain management with promising probudur study results MSN Tue, 18 Feb 2025 02:54:20 GMT
• virpax pharmaceuticals advances pain management with promising probudur study results MSN Mon, 17 Feb 2025 01:24:28 GMT
• virpax pharmaceuticals advances pain management with promising probudur study results MSN Sun, 16 Feb 2025 09:48:08 GMT
• Penny Stock Virpax Pharmaceuticals Surges On US Army-Performed Preclinical Study For Pain Candidate Yahoo Finance Fri, 14 Feb 2025 08:00:00 GMT
• 12 health care stocks moving in friday's pre-market session - artiva biotherapeutics (nasdaq:artv) Benzinga Fri, 14 Feb 2025 08:00:00 GMT
• breakthrough in pain relief: virpax pharmaceuticals soars with us army collaboration Meltyfan Fri, 14 Feb 2025 08:00:00 GMT
• Military Breakthrough: New Pain Control Drug Shows 96-Hour Combat Effectiveness in Army Tests Stock Titan Thu, 13 Feb 2025 08:00:00 GMT
• Virpax reports positive study results for pain management drug Investing.com Thu, 13 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals confirms results with u.s. army with probudur TipRanks Thu, 13 Feb 2025 08:00:00 GMT
• promising nanotechnology stocks to follow today - february 11th MarketBeat Wed, 12 Feb 2025 21:20:40 GMT
• promising nanotechnology stocks to watch today - february 06th MarketBeat Mon, 10 Feb 2025 08:00:00 GMT
• promising nanotechnology stocks to watch today – february 06th Armenian Reporter Sat, 08 Feb 2025 08:00:00 GMT
• nanotechnology stocks to add to your watchlist - february 04th MarketBeat Sat, 08 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals inc (vrpx) stock: what the analysts are saying The News Heater Fri, 07 Feb 2025 15:42:12 GMT
• virpax pharmaceuticals appoints charn deol as independent directorvirpax pharmaceuticals, inc. (nasdaq:vrpx) announced on february... Defense World Fri, 07 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals appoints new independent director by investing.com Investing.com Australia Fri, 07 Feb 2025 03:26:09 GMT
• 4 publicly traded philadelphia-area life sciences companies raise $34m The Business Journals Thu, 06 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals appoints new independent director Investing.com Thu, 06 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals appoints charn deol as independent director TipRanks Thu, 06 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals highlights leadership contributions at clinical trial conference MSN Thu, 06 Feb 2025 08:00:00 GMT
• virpax pharmaceuticals director resigns due to compliance by investing.com Investing.com Canada Wed, 05 Feb 2025 07:28:35 GMT
• virpax pharmaceuticals highlights leadership contributions at clinical trial conference MSN Tue, 04 Feb 2025 10:13:19 GMT
• virpax pharmaceuticals director resigns due to compliance Investing.com Tue, 04 Feb 2025 08:00:00 GMT
• best nanotechnology stocks to follow today - january 30th MarketBeat Mon, 03 Feb 2025 08:00:00 GMT
• promising nanotechnology stocks to follow today - february 02nd MarketBeat Sun, 02 Feb 2025 08:00:00 GMT
• best nanotechnology stocks to follow today - january 30th MarketBeat Sun, 02 Feb 2025 08:00:00 GMT
• best nanotechnology stocks to follow today - january 30th MarketBeat Fri, 31 Jan 2025 21:06:05 GMT
• vrpx - virpax pharmaceuticals inc latest stock news & market updates StockTitan Fri, 31 Jan 2025 18:07:10 GMT
• vrpx - virpax pharmaceuticals, inc. latest stock news & market updates StockTitan Fri, 31 Jan 2025 18:07:10 GMT
• spartan capital securities serves as sole placement agent in virpax pharmaceuticals’ $6 million follow-on offering GlobeNewswire Fri, 31 Jan 2025 09:36:43 GMT
• virpax's matthew barnes to present at outsourcing in clinical trials conference Business Wire Fri, 31 Jan 2025 08:00:00 GMT
• clinical trials innovation: virpax leadership takes center stage at elite oct conference Stock Titan Fri, 31 Jan 2025 08:00:00 GMT
• Virpax Pharmaceuticals, Inc. Announces Closing of $6.0 Million Public Offering of Common Stock and Pre-Funded Warrants Business Wire Thu, 30 Jan 2025 08:00:00 GMT
• spartan capital securities serves as sole placement agent in virpax pharmaceuticals’ $6 million follow-on offering GlobeNewswire Thu, 30 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals closes of $6.0 million public offering of common stock citybiz Thu, 30 Jan 2025 08:00:00 GMT
• virpax secures critical $6m funding: what this means for probudur's future Stock Titan Thu, 30 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals raises $6m and signs investor agreements TipRanks Thu, 30 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals prices of $6 million public offering of common stock citybiz Tue, 28 Jan 2025 19:05:47 GMT
• virpax pharmaceuticals sets public offering at $0.20 per share Investing.com Tue, 28 Jan 2025 08:00:00 GMT
• virpax secures critical $6m funding: game-changing move for probudur development Stock Titan Tue, 28 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals, inc. announces pricing of $6 million public offering of common stock and pre-funded warrants Business Wire Tue, 28 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals announces $6 mln public offering for pain relief innovations Nasdaq Tue, 28 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals raises $6m and signs investor agreements TipRanks Mon, 27 Jan 2025 08:00:00 GMT
• virpax pharmaceuticals granted nasdaq listing extension Investing.com Wed, 08 Jan 2025 03:17:26 GMT
• virpax pharmaceuticals granted nasdaq listing extension Investing.com Tue, 07 Jan 2025 08:00:00 GMT
Virpax Pharmaceuticals, Inc(NASDAQ:VRPX) 
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spr...
Website: http://www.virpaxpharma.com
Founded: 2016
CEO: Anthony P. Mack
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends